BAHAMA, N.C. – A North Carolina biotechnology company sold $165,000 in shares in a private stock offering, according to a Securities and Exchange Commission filing.
NeuroPro Therapeutics filed the Form D on Aug. 3. It did not disclose what it intended to do with the proceeds.
The company, founded on Jan. 27, 2014, is owned and operated by Daryl W. Hochman at 9803 Colt Drive in Bahama, North Carolina.
NeuroPro Therapeutics is developing a novel, nanoparticle-based imaging technique for the treatment of epilepsy.
The Form D was signed by Byron B. Kirkland, partner of Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P.
NeuroPro Therapeutics claimed a Rule 506 (b) exemption. Companies relying on the Rule 506 exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after selling shares.
The form can be found at:
https://www.sec.gov/Archives/edgar/data/1681407/000168140716000001/xslFormDX01/primary_doc.xml
Note: This story is from the North Carolina Business News Wire, a service of UNC-Chapel Hill’s School of Media and Journalism
